Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001826466-23-000014
Filing Date
2023-04-10
Accepted
2023-04-10 12:04:25
Documents
42
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nika-20221231x10k.htm   iXBRL 10-K 392127
7 EXHIBIT 31.1 nika-202212631xex31d1.htm EX-31.1 7583
8 EXHIBIT 32.1 nika-202212631xex32d1.htm EX-32.1 3432
  Complete submission text file 0001826466-23-000014.txt   1985337

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nika-20221231.xsd EX-101.SCH 16597
3 XBRL CALCULATION FILE nika-20221231_cal.xml EX-101.CAL 23555
4 XBRL DEFINITION FILE nika-20221231_def.xml EX-101.DEF 49485
5 XBRL LABEL FILE nika-20221231_lab.xml EX-101.LAB 147659
6 XBRL PRESENTATION FILE nika-20221231_pre.xml EX-101.PRE 120656
36 EXTRACTED XBRL INSTANCE DOCUMENT nika-20221231x10k_htm.xml XML 145419
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56234 | Film No.: 23810262
SIC: 3790 Miscellaneous Transportation Equipment